Discover 767 paid clinical trials in Elk Grove, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 767
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
for
Lower Back Pain
Location: Napa CA
Sponsor: Centrexion Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07122453
Phase1, Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Napa CA, Reno NV, Pasadena CA, Tustin CA, La Jolla CA,
Sponsor: Ambros Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07210515
Phase3, Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Napa CA, Reno NV, Santa Monica CA, Eugene OR,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Walnut Creek CA, Sherman Oaks CA, Glendale CA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07484217
Phase3, Recruiting
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
for
Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Location: Walnut Creek CA, Provo UT, Frisco TX, Port Lavaca TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1 - 6
Code: NCT07406360
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: Walnut Creek CA, San Ramon CA, Lancaster CA, Newhall CA,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase3, Recruiting
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
for
Binge-Eating Disorder
Location: Walnut Creek CA, Encino CA, West Covina CA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT06413433
Phase3, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Napa CA, Santa Rosa CA, Burbank CA, Duarte CA,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase3, Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Napa CA, Santa Rosa CA, Mission Hills CA, Tarzana CA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
for
Metastatic Small Intestinal Adenocarcinoma,
Location: Napa CA, Santa Rosa CA, Carson City NV, Reno NV,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04205968
Phase2, Recruiting
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Napa CA, Santa Rosa CA, Palo Alto CA, Reno NV,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500455
Phase3, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Napa CA, Santa Rosa CA, Palo Alto CA, Burbank CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06475989
Phase3, Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma